Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Shuiwang Qing

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112341595, A5157877223. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: 4 papers · 2019: 1 paper · 2020: 2 papers · 2021: 3 papers

Papers 13

  1. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. Co-author DOI 10.1111/cas.14486↗
  2. Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy. Co-author DOI 10.3389/fonc.2021.688576↗
  3. Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Cons… Co-author DOI 10.3389/fonc.2021.729490↗
  4. Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study. Co-author DOI 10.1177/1758835920977155↗
  5. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of m… Co-author DOI 10.20892/j.issn.2095-3941.2019.0101↗
  6. Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Tar… Co-author DOI 10.1016/j.ijrobp.2019.01.075↗
  7. Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1002/cam4.1553↗
  8. Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD scor… Co-author DOI 10.1016/j.radonc.2018.08.012↗
  9. Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matc… Co-author DOI 10.2147/cmar.s163655↗
  10. Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pa… Co-author DOI 10.2147/cmar.s166713↗
  11. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.1164↗
  12. Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I st… Co-author DOI 10.1186/s13014-016-0760-1↗
  13. Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally adva… Co-author DOI 10.1136/bmjopen-2016-013220↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangsen Cao · 13 shared papers, 2016–2021 · strength 1.21
  2. Huojun Zhang · 13 shared papers, 2016–2021 · strength 1.21
  3. Xiaofei Zhu · 12 shared papers, 2016–2021 · strength 1.11
  4. Yuxin Shen · 10 shared papers, 2016–2021 · strength 0.88
  5. Yusheng Ye · 3 shared papers, 2020–2021 · strength 0.35
  6. Lingong Jiang · 3 shared papers, 2020–2021 · strength 0.35
  7. Ting‐Shi Su · 2 shared papers, 2020–2021 · strength 0.23
  8. Wenyu Liu · 2 shared papers, 2018–2021 · strength 0.19
  9. Xixu Zhu · 1 shared paper, 2021 · strength 0.12
  10. Di Chen · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.